Share this post on:

Product Name :
AUZ-454

Search keywords :
AUZ 454

drugId :
null

Target Vo:
Tyrosine-protein kinase receptor FLT3

Target Vo Short Name :
FLT3

Moa_Name:
Tyrosine-protein kinase receptor FLT3 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alexa Fluor® 488-conjugated AffiniPure Goat Anti-Mouse IgG H&L
Alexa Fluor® 647-conjugated AffiniPure Goat Anti-Mouse IgG H&L
Phospho-STAT1 (Tyr701) Antibody: Phospho-STAT1 (Tyr701) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 87 kDa, targeting to Phospho-STAT1 (Tyr701). It can be used for ICC/IF,WB,IHC-F,IHC-P,IP,ELISA assays with tag free, in the background of Human, Mouse, Rat, Monkey.

Share this post on:

Author: Betaine hydrochloride